StockData

Aspen Neuroscience, Inc. (ASPE) stock

ASPEPharmaceutical PreparationsFiscal year ends December 31
$14.89+14.88 (+148800.00%)

Close on Oct 30, 2026Market cap –P/E –Yield –

Key statistics

Valuation at the latest close; fundamentals over fiscal

Valuation

Market cap
–
P/E ratio
–
Price to sales
–
Price to book
–
Dividend yield
–
Free cash flow yield
–

Trading

Previous close
$0.01
Open
$14.70
Day's range
$11.60 – $14.90
Volume
1,322,735
Average volume (20 days)
100,403

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Oct 30, 2026. The S&P 500 is measured by the SPY fund.

PeriodASPES&P 500DifferenceASPE per yearS&P 500 per year
1 month+148800.0%-0.9%+148800.9 pts
3 months+148800.0%+2.1%+148797.9 pts
Year to date+148800.0%+11.7%+148788.3 pts
1 year+148800.0%+12.4%+148787.6 pts
3 years+148800.0%+88.6%+148711.4 pts+1041.9%+23.5%
5 years+148800.0%+75.9%+148724.1 pts+331.1%+12.0%
10 years+148800.0%+316.4%+148483.6 pts+107.6%+15.3%

Aspen Neuroscience stock: common questions

What is Aspen Neuroscience's stock price?

ASPE closed at $14.89 on Oct 30, 2026, up 148800.00% on the day.

Does Aspen Neuroscience pay a dividend?

No. Aspen Neuroscience has not paid a cash dividend over the last twelve months.

How has ASPE stock performed over the past year?

Including dividends, ASPE returned +148800.0% over the past year, against +12.4% for the S&P 500.

Who are Aspen Neuroscience's competitors?

Companies most similar to Aspen Neuroscience by business, industry and size include LLY, JNJ, ABBV, MRK, AZN.